Press Releases

 
Press Releases
  Date Title and Summary View
Aug 16, 2016
FREMONT, Calif., Aug. 16, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a CNS company focused on providing rapid symptom relief to patients using the Company's proprietary intracutaneous delivery system, today announced that it has entered into a securities purchase agreement to sell shares of its common stock and warrant...
Aug 10, 2016
FREMONT, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), an emerging CNS company focused on providing rapid symptom relief to patients using the Company's proprietary intracutaneous delivery system, today announced financial results for the second quarter ended June 30, 2016. "With the recent ...
Jul 25, 2016
FREMONT, Calif., July 25, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), an emerging CNS company focusing on providing rapid symptom relief to patients using the Company's proprietary transdermal delivery system, today announced the dosing of its first subject in its registration-enabling pivotal efficacy trial (the Zotrip...
Jun 17, 2016
FREMONT, Calif., June 17, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs, today announced the enrollment of its first subject in a pivotal efficacy trial of its ZP-Triptan patch treatment for acute mi...
May 12, 2016
FREMONT, Calif., May 12, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs, today announced financial results for the first quarter ended March 31, 2016. "Zosano is making progress towards initiating ou...
May 9, 2016
FREMONT, Calif., May 09, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage specialty pharmaceutical company with proprietary technology for the dermal delivery of drugs, announced today that it named Mr. John P. Walker Chairman of the Board."We are honored to have John joining us at such a transfor...
May 2, 2016
FREMONT, Calif., May 02, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) today announced that it plans to report financial results for the first quarter of 2016 on Thursday, May 12, 2016. Zosano will host a conference call and webcast to provide an update at 4:30 pm ET (1:30 pm PT) that day. The call will be hos...
Mar 29, 2016
FREMONT, Cali., March 29, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical stage specialty pharmaceutical company with proprietary microneedle patch technology for the delivery of drugs through the skin, today announced financial results for the fourth quarter and year ended December 31, 2015. The company also pro...
Mar 21, 2016
FREMONT, Calif., March 21, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN) today announced that it plans to report financial results for the fourth quarter and full year 2015 on Tuesday, March 29, 2016. Zosano will host a conference call and webcast to provide a corporate update at 4:30 p.m. ET (1:30 p.m. PT) that day. The cal...
Mar 9, 2016
FREMONT, Calif., March 09, 2016 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage specialty pharmaceutical company, today announced that Konstantinos Alataris, Ph.D., President and Chief Executive Officer of Zosano, will provide a company overview at the 28th Annual ROTH Conference on March 14, 2016. The presentat...
Page: FirstPrevious
3
... NextLast
= add release to Briefcase